These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16507129)

  • 1. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
    Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
    Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
    Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
    Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome.
    Ittah M; Gottenberg JE; Proust A; Hachulla E; Puechal X; Loiseau P; Mariette X; Miceli-Richard C
    Genes Immun; 2005 Aug; 6(5):457-8. PubMed ID: 15933742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome.
    Pertovaara M; Antonen J; Hurme M
    Ann Rheum Dis; 2006 May; 65(5):666-70. PubMed ID: 16166103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
    Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
    Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
    Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
    Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
    Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X
    Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome?
    Sellam J; Miceli-Richard C; Gottenberg JE; Proust A; Ittah M; Lavie F; Loiseau P; Mariette X
    Rheumatology (Oxford); 2008 Apr; 47(4):437-41. PubMed ID: 18296721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome.
    Gestermann N; Koutero M; Belkhir R; Tost J; Mariette X; Miceli-Richard C
    Eur Cytokine Netw; 2012; 23(4):166-72. PubMed ID: 23302156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-10 promoter polymorphisms in primary Sjogren's syndrome.
    Willeke P; Gaubitz M; Schotte H; Becker H; Domschke W; Schlüter B
    Scand J Rheumatol; 2008; 37(4):293-9. PubMed ID: 18612930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.
    Miceli-Richard C; Gestermann N; Ittah M; Comets E; Loiseau P; Puechal X; Hachulla E; Gottenberg JE; Lebon P; Becquemont L; Mariette X
    Arthritis Rheum; 2009 Jul; 60(7):1991-7. PubMed ID: 19565491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling.
    Gestermann N; Mekinian A; Comets E; Loiseau P; Puechal X; Hachulla E; Gottenberg JE; Mariette X; Miceli-Richard C
    Genes Immun; 2010 Jul; 11(5):432-8. PubMed ID: 20535138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome.
    Cay HF; Sezer I; Dogan S; Felek R; Aslan M
    Clin Exp Rheumatol; 2012; 30(6):843-9. PubMed ID: 22703762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
    Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M; Pöllänen P; Lehtimäki T
    Rheumatology (Oxford); 2004 Dec; 43(12):1476-9. PubMed ID: 15316122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.
    Eilertsen GØ; Van Ghelue M; Strand H; Nossent JC
    Rheumatology (Oxford); 2011 Dec; 50(12):2197-205. PubMed ID: 21984763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.